Two Bear Capital (TBC) was founded and is led by venture capitalist and Montana philanthropist Michael Goguen with professionals in Whitefish, Montana, the San Francisco Bay area, San Diego and Boston. TBC invests in early stage companies with disruptive innovations at the intersections of biotech, bioinformatics, machine learning / AI and cybersecurity that are positioned to deliver dramatically better solutions to the most critical problems affecting human health, security and wellness.
Employees: 11-50
Founded date: 2019
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 30.06.2021 | Novoron Bi... | novoron.co... | $19.19M | United Sta... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 22.09.2021 | Blue Bear Capital closes $150M fund | Blue Bear Capital, a venture and growth equity firm focused on investing in AI-driven technologies f... | pitchbook.... |
| 21.09.2021 | Blue Bear Capital raises $150M to fund climate, energy and i... | Blue Bear Capital has raised a new $150 million fund that will be used to find and invest in startup... | techcrunch... |
| 21.09.2021 | Blue Bear Capital : Closes Oversubscribed $150 Million Fund ... | Blue Bear Capital, a venture and growth equity firm focused on AI-powered solutions for the world’s ... | marketscre... |
| 28.07.2021 | Digital therapy: focus on results, not technology: investmen... | Digital therapy: focus on results, not technology: investments, trends, new development challenges. ... | startupjed... |
| 28.07.2021 | Цифровая терапия — фокус на результат, а не на технологию: и... | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития... | startupjed... |
| 10.07.2020 | Inimmune raises $22 Million in Series A Funding Led by Two B... | MISSOULA, Mont., July 9, 2020 /PRNewswire/ -- Inimmune, www.inimmune.com, a biotechnology company de... | marketscre... |